Evaluation status available after sign-in
About the journal
NAR Cancer is an open-access journal published by Oxford University Press in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 2,391 USD. Declared review time at DOAJ: 13 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Oxford University Press
- ISSN
- 2632-8674
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,391 USD
- Articles in DOAJ
- 0
- Declared review time
- 13 weeks
- Declared peer-review model
- other
- Official website
- https://academic.oup.com/narcancer
Index listings
- DOAJ · 2020-07-22
- MEDLINE · 1974-01-01
- Indexing
- DOAJ · MEDLINE
- APC
- 2,391 USD
- Declared review time (DOAJ)
- 13 weeks
- Actual review time (measured)
- 146 days received→accepted — computed from PubMed (n=93)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
13weeks
Works in OpenAlex
328
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
33
i10-index
156
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-03
- Added to DOAJ
- 2020-07-22
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- PMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 98%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Nucleic Acids Research cancer
- Source type
- journal
- NLM unique ID (PubMed)
- 101769553
Classification4
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogensScience: Biology (General): Genetics
LCC codes
RC254-282QH426-470
Subject areas
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
Show all subjects (75)
- Chromatin Remodeling and Cancer
- Cancer-related molecular mechanisms research
- PARP inhibition in cancer therapy
- RNA Research and Splicing
- PARP inhibition in cancer therapy
- RNA Research and Splicing
- PARP inhibition in cancer therapy
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
- DNA and Nucleic Acid Chemistry
- Genomics and Chromatin Dynamics
- Genomics and Chromatin Dynamics
- RNA and protein synthesis mechanisms
- RNA and protein synthesis mechanisms
- Cancer-related gene regulation
- Cancer-related gene regulation
- BRCA gene mutations in cancer
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Glioma Diagnosis and Treatment
- Advanced biosensing and bioanalysis techniques
- DNA and Nucleic Acid Chemistry
- Cancer-related Molecular Pathways
- RNA regulation and disease
- DNA and Nucleic Acid Chemistry
- Cancer-related Molecular Pathways
- Cancer therapeutics and mechanisms
- Cancer therapeutics and mechanisms
- RNA Interference and Gene Delivery
- Cancer therapeutics and mechanisms
- Genetic factors in colorectal cancer
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- Breast Cancer Treatment Studies
- PI3K/AKT/mTOR signaling in cancer
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Single-cell and spatial transcriptomics
- RNA Interference and Gene Delivery
- Carcinogens and Genotoxicity Assessment
- Prostate Cancer Treatment and Research
- Single-cell and spatial transcriptomics
- Circular RNAs in diseases
- Single-cell and spatial transcriptomics
- MicroRNA in disease regulation
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Ubiquitin and proteasome pathways
- Chromatin Remodeling and Cancer
- Ferroptosis and cancer prognosis
- Chromatin Remodeling and Cancer
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
- Ferroptosis and cancer prognosis
- Carcinogens and Genotoxicity Assessment
- Carcinogens and Genotoxicity Assessment
Keywords (DOAJ)
- cancer
- oncology
- dna
- genomics
- nucleic acids
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ